Ann: PharmAust to present at NWR Virtual Healthcare Conference, page-92

Same posters making the same noises they made back just before the canine cancer option was rejected.
Roger claiming a deal with BP just around the corner which could be worth $2b, posters stating was a great job Roger was doing and that the sp would be anywhere from $1 to $300.
Posters also posting how great Roger looked when in facted even back then he was looking jaded.

Posters howling me down when I suggested that the option would be rejected due to small dog numbers.
Howled me down when I suggested it was time for Roger to step down.
Some posters have short memories as now it's MT quoting take over could be worth somewhere between $2.5b and $7b.
Same posters now going over board in trying to convince themselves that paa could be on a winner this time and trying to shut down anyone who sees things differently.
Will the FDA give ODD approval well in my opinion its 50 - 50 chance
Will a BP make any sort of offer, no one knows
Will PAA phase 2 MND trial be successful well on current data it would appear so but many drugs which have shown great phase 1 results have failed once the trial participants have increased.